MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Nigrostriatal dopaminergic synapse deficiency"

  • MDS Virtual Congress 2021

    DAT-SPECT in old onset Parkinson’s disease: should we trust?

    G. Palermo, S. Giannoni, D. Frosini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: . Background: Scans without evidence of dopaminergic deficit (SWEDD) refers to patients clinically diagnosed with Parkinson’s disease (PD), but show normal findings on dopamine…
  • MDS Virtual Congress 2021

    Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study

    K. Steidel, M. Ruppert, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, D. Pedrosa, C. Eggers (Marburg, Germany)

    Objective: To investigate the longitudinal course of nigrostriatal metabolic and dopaminergic dysfunction and its impact on symptom severity in Parkinson's disease (PD) patients using a…
  • MDS Virtual Congress 2021

    Eyelid opening apraxia as the first manifestation of Creutzfeldt- Jakob disease with 99mTc-TRODAT-1 brain SPECT study

    G. Fabiani, R. Filho, E. Hummelgen (Cg Sul, Brazil)

    Objective: Our objective is to report a case of sporadic CJD (CJD) in a 57-years-old male patient. It started with severe insomnia followed by eyelid…
  • MDS Virtual Congress 2020

    Sex-related longitudinal change of motor features and biological biomarkers in early Parkinson’s disease from the PPMI cohort

    M. Picillo, S. Bressman, C. Coffey, N. Dahodwala, R. Sanders-Pullman, C. Tanner, A. Amara (Salerno, Italy)

    Objective: We aim to describe sex-related longitudinal changes in (1) motor features and motor aspects of experiences of daily living and (2) biologic measures as…
  • MDS Virtual Congress 2020

    Increased expression of conexin 36 in rodent model of Parkinson disease

    M. Viegas, L. Santos, F. Scorza, C. Scorza, A. Rodrigues, A. Almeida (SJD, Brazil)

    Objective: To evaluate changes in non-synaptic mechanisms associated with the procedures to reproduce the neurophysiological conditions typical of Parkinson's disease (PD). Background: Many mechanisms that…
  • MDS Virtual Congress 2020

    Alpha-synuclein preformed fibril (PFF)-triggered synucleinopathy recapitulates neurochemical features of human PD: A PET study in rats

    C. Sortwell, J. Patterson, C. Kemp, K. Miller, A. Stoll, M. Duffy, K. Luk, V. Sossi (Grand Rapids, MI, USA)

    Objective: To investigate longitudinal dopaminergic deficits and similarity to human Parkinson’s disease (PD) using PET imaging in the rat alpha-synuclein (a-syn) preformed fibril (PFF) model.…
  • MDS Virtual Congress 2020

    Genetic Profiling of Early Synucleinopathy in Rat Nigrostriatal Dopamine Neurons

    J. Patterson, C. Kemp, M. Duffy, J. Howe, C. Russell, A. Stoll, K. Miller, J. Beck, S. Counts, K. Steece-Collier, K. Luk, C. Sortwell (Grand Rapids, MI, USA)

    Objective: Identification of changes in gene expression in rat nigral neurons associated with early phases of synucleinopathy. Background: Early phases of synucleinopathies such as Parkinson’s…
  • MDS Virtual Congress 2020

    In vivo imaging of presynaptic terminal loss in early Parkinson’s disease

    A. Delva, D. Van Weehaeghe, M. Koole, K. Van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To determine the magnitude and anatomical extent of presynaptic terminal damage in early Parkinson’s disease (PD) in vivo, we performed a PET study with…
  • 2019 International Congress

    Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease

    OD. Kwon, SG. Park, SB. Lee, JA. Park (Daegu, Republic of Korea)

    Objective: This study was performed to identify any relationship between the amount of decline of receptor uptake of CIT and Mini-Mental State Examination(MMSE) score in…
  • 2019 International Congress

    Therapeutic intervention of LRRK2 kinase inhibitors in Vps35 p.D620N Parkinsonism

    I. Tatarnikov, J. Follett, J. Fox, M. Farrer (Vancouver, BC, Canada)

    Objective: To explore the therapeutic potential of LRRK2 kinase inhibitors in a Vps35 p.D620N mouse model of Parkinsonsim. Background: The discovery of a missense mutation, Vps35 p.D620N…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley